首页 | 本学科首页   官方微博 | 高级检索  
     

恶性脑胶质瘤局部治疗新技术及疗效观察
引用本文:易林华,李安民,傅相平,闫润民,查韦光. 恶性脑胶质瘤局部治疗新技术及疗效观察[J]. 解放军医学高等专科学校学报, 2009, 0(3): 403-405
作者姓名:易林华  李安民  傅相平  闫润民  查韦光
作者单位:解放军总医院第一附属医院神经外科,北京100037
摘    要:目的总结和分析恶性脑胶质细胞瘤局部治疗新技术及临床疗效。方法我科收治379例恶性脑胶质细胞瘤患者,根据肿瘤部位及性质不同采用不同的治疗方法,术后定期复诊及随访。结果随访时间6-84个月。6个月之内有效率达88.9%。6个月以上,临床治愈39例。影像学治愈24例,治愈率达16.6%。1年生存期66.8%,3年生存期43.2%,5年生存期30.1%,7年生存期23%。与传统治疗相比有显著差别。结论脑胶质细胞瘤恶性程度高,传统治疗效果差,不同部位采用相应联合新技术治疗能有效提高患者生存质量,延长其生命。

关 键 词:恶性脑胶质瘤  新技术  疗效

Observe on the Curative Effect of New Local Treatment Technic in Malignant Encephalic Glioma
Yi Lin-hua,Li An-min,Fu Xiang-ping,Yan Run-rain,Zha Wei-guang. Observe on the Curative Effect of New Local Treatment Technic in Malignant Encephalic Glioma[J]. Clinical Journal of Medical Officer, 2009, 0(3): 403-405
Authors:Yi Lin-hua  Li An-min  Fu Xiang-ping  Yan Run-rain  Zha Wei-guang
Affiliation:( Department of Neurosurgery, First Affiliated Hospital of PLA General Hospital. Beijing 100037, China)
Abstract:Objective To summarize and analyze a new treatment technic of malignant encephalic glioma and its clinic curative effect. Methods 379 patients were treated by different method according to the tumor' s position and quality, and reexamined after operation. Results Follow-up of the patients from 6 to 84 months is showed as follow: The effective rate was 88.9% within 6 months. After 6 monthes, there is 39 cases of clinical cure,24 cases of mageology cure, total cure rate was 16.6%. A survival rate of 1 year reached 66.8% , 3 years reached 43.2% , and 5 years reached 30.1%, 7 years reached 23%. There are significantly difference compared with traditional treatment. Conclusion The malignancy grade of encephalic glioma is very high, and tradition- al treatment have unsatisfied effect. The application of new treatment technic on gliomas may improve the life quality of patients and increase their life span.
Keywords:malignant encephalic glioma  new treatment technic  curative effect
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号